You are here

Home

Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Vasan, Ramachandran S  [Clear All Filters]
Journal Article
Spartano NL, Demissie S, Himali JJ, Dukes KA, Murabito JM, Vasan RS, Beiser AS, Seshadri S.  2019.  Accelerometer-determined physical activity and cognitive function in middle-aged and older adults from two generations of the Framingham Heart Study.. Alzheimers Dement (N Y). 5:618-626.
Spartano NL, Davis-Plourde KL, Himali JJ, Andersson C, Pase MP, Maillard P, DeCarli C, Murabito JM, Beiser AS, Vasan RS et al..  2019.  Association of Accelerometer-Measured Light-Intensity Physical Activity With Brain Volume: The Framingham Heart Study.. JAMA Netw Open. 2(4):e192745.
Tynkkynen J, Chouraki V, van der Lee SJ, Hernesniemi J, Yang Q, Li S, Beiser A, Larson MG, Sääksjärvi K, Shipley MJ et al..  2018.  Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts.. Alzheimers Dement. 14(6):723-733.
Peloso GM, Beiser AS, Satizabal CL, Xanthakis V, Vasan RS, Pase MP, DeStefano AL, Seshadri S.  2020.  Cardiovascular health, genetic risk, and risk of dementia in the Framingham Heart Study.. Neurology. 95(10):e1341-e1350.
McGrath ER, Himali JJ, Xanthakis V, Duncan MS, Schaffer JE, Ory DS, Peterson LR, DeCarli C, Pase MP, Satizabal CL et al..  2020.  Circulating ceramide ratios and risk of vascular brain aging and dementia.. Ann Clin Transl Neurol.
McGrath ER, Himali JJ, Levy D, Conner SC, Pase MP, Abraham CR, Courchesne P, Satizabal CL, Vasan RS, Beiser AS et al..  2019.  Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study.. PLoS One. 14(3):e0213321.
Raman MR, Himali JJ, Conner SC, DeCarli C, Vasan RS, Beiser AS, Seshadri S, Maillard P, Satizabal CL.  2018.  Circulating Vascular Growth Factors and Magnetic Resonance Imaging Markers of Small Vessel Disease and Atrophy in Middle-Aged Adults.. Stroke. 49(9):2227-2229.
Wolters FJ, Yang Q, Biggs ML, Jakobsdottir J, Li S, Evans DS, Bis JC, Harris TB, Vasan RS, Zilhao NR et al..  2019.  The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE).. PLoS One. 14(7):e0219668.
Vasan RS, Short MI, Niiranen TJ, Xanthakis V, DeCarli C, Cheng S, Seshadri S, Mitchell GF.  2019.  Interrelations Between Arterial Stiffness, Target Organ Damage, and Cardiovascular Disease Outcomes.. J Am Heart Assoc. 8(14):e012141.
Spartano NL, Davis-Plourde KL, Himali JJ, Murabito JM, Vasan RS, Beiser AS, Seshadri S.  2019.  Self-Reported Physical Activity and Relations to Growth and Neurotrophic Factors in Diabetes Mellitus: The Framingham Offspring Study.. J Diabetes Res. 2019:2718465.
Adams S, Conner S, Himali JJ, Beiser A, Vasan RS, Seshadri S, Pase MP.  2018.  Vascular risk factor burden and new-onset depression in the community.. Prev Med. 111:348-350.

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer